TY - JOUR
T1 - Intimate partner violence against pregnant women during the COVID-19 pandemic
T2 - a systematic review and meta-analysis
AU - Huldani, Huldani
AU - Kamal Abdelbasset, Walid
AU - Abdalkareem Jasim, Saade
AU - Suksatan, Wanich
AU - Turki Jalil, Abduladheem
AU - Thangavelu, Lakshmi
AU - Fakri Mustafa, Yasser
AU - Karami, Maryam
N1 - Publisher Copyright:
© 2022 Taylor & Francis Group, LLC.
PY - 2022
Y1 - 2022
N2 - This systematic review and meta-analysis aimed to estimate the pooled prevalence of (intimate partner violence) IPV against pregnant women in the COVID-19 pandemic. A literature search was conducted in PubMed, Web of Science, and Scopus for observational studies regarding the prevalence of IPV against pregnant women during the COVID-19 pandemic. The search was performed with the following keywords: intimate partner violence, domestic violence, battered women, wife assault, partner assault, wife abuse, partner abuse, femicide, domestic homicide, pregnancy, gestation, pregnant women, COVID-19, SARS-CoV-2, 2019-nCoV, Coronavirus Disease-19, 2019 Novel Coronavirus, Wuhan Coronavirus, SARS Coronavirus 2, Wuhan Seafood Market Pneumonia Virus. Heterogeneity between the studies was assessed using Cochran’s Q test and I2 index. In addition, a random-effects model was used to estimate the prevalence of IPV. Data analysis was performed in Stata software version 16. Six articles met our inclusion criteria, which were conducted on 2213 pregnant women. The pooled prevalence of total IPV was estimated at 22 percent (95 percent Confidence Interval [CI]: 4–40 percent). Moreover, the pooled prevalence of psychological, physical, and sexual violence was reported to be 24 percent (95 percent CI: 13–35 percent), 14 percent (95 percent CI: 7–20 percent), and 6 percent (95 percent CI: 4–9 percent), respectively. Publication bias was significant (P =.01). According to the results, IPV against pregnant women has been relatively prevalent during the COVID-19 pandemic. Therefore, identifying the women who are at the risk of IPV is essential to preventing the consequences of maternal-fetal abuse and designing strategies to facilitate the reporting of violence during pandemics.
AB - This systematic review and meta-analysis aimed to estimate the pooled prevalence of (intimate partner violence) IPV against pregnant women in the COVID-19 pandemic. A literature search was conducted in PubMed, Web of Science, and Scopus for observational studies regarding the prevalence of IPV against pregnant women during the COVID-19 pandemic. The search was performed with the following keywords: intimate partner violence, domestic violence, battered women, wife assault, partner assault, wife abuse, partner abuse, femicide, domestic homicide, pregnancy, gestation, pregnant women, COVID-19, SARS-CoV-2, 2019-nCoV, Coronavirus Disease-19, 2019 Novel Coronavirus, Wuhan Coronavirus, SARS Coronavirus 2, Wuhan Seafood Market Pneumonia Virus. Heterogeneity between the studies was assessed using Cochran’s Q test and I2 index. In addition, a random-effects model was used to estimate the prevalence of IPV. Data analysis was performed in Stata software version 16. Six articles met our inclusion criteria, which were conducted on 2213 pregnant women. The pooled prevalence of total IPV was estimated at 22 percent (95 percent Confidence Interval [CI]: 4–40 percent). Moreover, the pooled prevalence of psychological, physical, and sexual violence was reported to be 24 percent (95 percent CI: 13–35 percent), 14 percent (95 percent CI: 7–20 percent), and 6 percent (95 percent CI: 4–9 percent), respectively. Publication bias was significant (P =.01). According to the results, IPV against pregnant women has been relatively prevalent during the COVID-19 pandemic. Therefore, identifying the women who are at the risk of IPV is essential to preventing the consequences of maternal-fetal abuse and designing strategies to facilitate the reporting of violence during pandemics.
KW - COVID-19
KW - domestic violence
KW - intimate partner violence
KW - pregnancy
KW - prevalence
UR - http://www.scopus.com/inward/record.url?scp=85133505132&partnerID=8YFLogxK
U2 - 10.1080/03630242.2022.2096755
DO - 10.1080/03630242.2022.2096755
M3 - Article
C2 - 35791678
AN - SCOPUS:85133505132
SN - 0363-0242
VL - 62
SP - 556
EP - 564
JO - Women and Health
JF - Women and Health
IS - 6
ER -